CPX-351 As First Intensive Therapy for Elderly Patients with AML
Ellen K. Ritchie(Cornell University), Gail J. Roboz(Cornell University), Sumaiya Miah(Cornell University), Pinkal Desai(NewYork–Presbyterian Hospital), Sangmin Lee(Janssen (United States)), Jeffrey Ball(Cornell University), Michael Samuel(NewYork–Presbyterian Hospital), Tania J. Curcio(Cornell University)
Cited by 6
Related Papers
Efficacy and Toxicity Management of 19-28z CAR T Cell Therapy in B Cell Acute Lymphoblastic Leukemia
|Science Translational Medicine|2014|2.5k
Durable Remissions with Ivosidenib in <i>IDH1</i> -Mutated Relapsed or Refractory AML
|New England Journal of Medicine|2018|1.4k